首页> 美国卫生研究院文献>Stem Cells International >Role of Nitric Oxide Nitric Oxide Synthase Soluble Guanylyl Cyclase and cGMP-Dependent Protein Kinase I in Mouse Stem Cell Cardiac Development
【2h】

Role of Nitric Oxide Nitric Oxide Synthase Soluble Guanylyl Cyclase and cGMP-Dependent Protein Kinase I in Mouse Stem Cell Cardiac Development

机译:一氧化氮一氧化氮合酶可溶性鸟苷酸环化酶和cGMP依赖性蛋白激酶I在小鼠干细胞心脏发育中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction and Aim. Nitric oxide (NO) can trigger cardiac differentiation of embryonic stem cells (ESCs), indicating a cardiogenic function of the NO synthetizing enzyme(s) (NOS). However, the involvement of the NO/NOS downstream effectors soluble guanylyl cyclase (sGC) and cGMP activated protein kinase I (PKG-I) is less defined. Therefore, we assess the involvement of the entire NO/NOS/sGC/PKG-I pathway during cardiac differentiation process. Methods. Mouse ESCs were differentiated toward cardiac lineages by hanging drop methodology for 21 days. NOS/sGC/PKG-I pathway was studied quantifying genes, proteins, enzymatic activities, and effects of inhibition during differentiation. Percentages of beating embryoid bodies (mEBs) were evaluated as an index of cardiogenesis. Results and Discussion. Genes and protein expression of enzymes were increased during differentiation with distinctive kinetics and proteins possessed their enzymatic functions. Exogenous administered NO accelerated whereas the blockade of PKG-I strongly slowed cardiogenesis. sGC inhibition was effective only at early stages and NOS blockade ineffective. Of NOS/sGC/PKG-I pathway, PKG-I seems to play the prominent role in cardiac maturation. Conclusion. We concluded that exogenous administered NO and other pharmacological strategies able to increase the activity of PKG-I provide new tools to investigate and promote differentiation of cardiogenic precursors.
机译:介绍和目标。一氧化氮(NO)可以触发胚胎干细胞(ESC)的心脏分化,表明NO合成酶(NOS)的心脏功能。然而,对NO / NOS下游效应物可溶性鸟苷酸环化酶(sGC)和cGMP激活的蛋白激酶I(PKG-1)的参与尚不清楚。因此,我们评估了心脏分化过程中整个NO / NOS / sGC / PKG-I途径的参与。方法。通过悬滴法21天将小鼠ESC分化为心脏谱系。研究了NOS / sGC / PKG-I途径对基因,蛋白质,酶活性和分化过程中抑制作用的定量作用。评价搏动的胚状体(mEBs)的百分比作为心源性指标。结果与讨论。酶的基因和蛋白质表达在分化过程中以独特的动力学增加,蛋白质具有其酶功能。外源给药的NO加速,而PKG-1的阻断强烈减慢了心脏发生。 sGC抑制仅在早期有效,而NOS阻断无效。在NOS / sGC / PKG-1途径中,PKG-1似乎在心脏成熟中起着重要作用。结论。我们得出的结论是,外源给药的NO和其他能够增加PKG-1活性的药理策略为研究和促进心源性前体的分化提供了新的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号